Clinical Regulatory Solutions

As global regulatory requirements continue to evolve our regulatory experts will help you navigate regulatory requirements throughout your product’s development lifecycle.

Across your clinical development journey, consider our Clinical Trial Regulatory Services a hub for all.

Regulatory Strategy

  • EU Regulatory pathways incl. clinical strategy – EMA, CE-marking and Notified Body interactions
  • US Regulatory pathways incl. clinical strategy – FDA

  • Clinical Trial Regulation (CTR)
  • Medical Device Regulation (MDR)
  • In-Vitro Diagnostic Regulation (IVDR)

Clinical Evidence

  • Literature studies
  • Clinical studies
    • Local single-centre to global multi-centre
    • Pre- to Post Market phase
    • Regulatory Authorities and Ethics Committees/Institutional Review Boards Submissions
    • Clinical Study Report (CSR)
    • Legal Representation
  • Clinical Evaluation Report (CER)
  • Readiness for inspections by Regulatory Authorities

Post Market

  • Post Market Surveillance (PMS)
  • Post Market Clinical Follow-up (PMCF) incl. design, conduct, analysis and reporting
  • CER updates

Contact

Talk to a clinical expert

Don’t hesitate to contact us if you have a clinical program or project coming up. We will provide you with more information on our operations model and provide you with a custom-made and budget-effective solution.

Come visit our booth at CPHI Barcelona 2023

Come to see the QbD Group at stand #3G73 at CPHI Conference in Barcelona. And after the conference…Eat & Connect with lifescience professionals at our QbD’s CPHI Networking Drink.